2
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Adjuvant Radiation Therapy in Pancreatic Carcinoma: A Reappraisal

Pages 745-746 | Published online: 11 Jun 2009
 

Abstract

Pancreatic carcinoma is clearly a disease that “gives cancer a bad name.” In general, it is refractory to single modality therapy using surgery radiation therapy, or chemotherapy. While only 10-15% of patients present with resectable disease, approximately 50% of patients with pancreatic carcinoma have only locoregional disease (non-resectable) at diagnosis. For these patients without distant metastases, some recent studies employing combined modality therapy show some promise for improving local control and possibly survival in this devastating disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.